To clarify whether PRMT3 regulates tau phosphorylation through its impact on H4R3me2a, we conducted a dot blot analysis of H4R3me2a in the EC region of 45 PART and 41 AD patients. This evidence concerns the gene MAPT and Alzheimer disease.